Sterling Pharma Solutions Expands US Operations

URLhttps://www.contractpharma.com/contents/view_break
SourceContract Pharma
Date Published10/02/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Sterling Pharma Solutions
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2020
Domestically, the work will be done:In-house
Country(ies) from which reshored:United Kingdom
City reshored to:Germantown
State(s) reshored to:WI
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredAPI, Active Pharmaceutical Ingredients
What domestic positive factors made reshoring more attractive?Lead time/Time to market, Proximity to customers/market, Skilled workforce availability/training
Find Reshoring Articles